Freestone Grove Partners LP Innoviva, Inc. Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 20,823 shares of INVA stock, worth $359,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,823
Previous 19,875
4.77%
Holding current value
$359,196
Previous $360 Million
16.1%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding INVA
# of Institutions
284Shares Held
80.3MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$124 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$108 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$82.1 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$74.1 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.2B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...